PE12598A1 - Formas zwitterionicas de trovafloxacina - Google Patents

Formas zwitterionicas de trovafloxacina

Info

Publication number
PE12598A1
PE12598A1 PE1996000633A PE00063396A PE12598A1 PE 12598 A1 PE12598 A1 PE 12598A1 PE 1996000633 A PE1996000633 A PE 1996000633A PE 00063396 A PE00063396 A PE 00063396A PE 12598 A1 PE12598 A1 PE 12598A1
Authority
PE
Peru
Prior art keywords
trovafloxacin
obtaining
pentahydrate
dry
main peaks
Prior art date
Application number
PE1996000633A
Other languages
English (en)
Spanish (es)
Inventor
Timothy Norris
David B Joseph
Douglas J M Allen
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PE12598A1 publication Critical patent/PE12598A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Physical Water Treatments (AREA)
  • Processing Of Solid Wastes (AREA)
PE1996000633A 1995-08-29 1996-08-26 Formas zwitterionicas de trovafloxacina PE12598A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US297595P 1995-08-29 1995-08-29

Publications (1)

Publication Number Publication Date
PE12598A1 true PE12598A1 (es) 1998-03-20

Family

ID=21703460

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1996000633A PE12598A1 (es) 1995-08-29 1996-08-26 Formas zwitterionicas de trovafloxacina

Country Status (30)

Country Link
EP (1) EP0850060A1 (pt)
JP (1) JP3188476B2 (pt)
KR (1) KR100343909B1 (pt)
CN (1) CN1190889A (pt)
AP (1) AP636A (pt)
AR (1) AR003985A1 (pt)
AU (1) AU704115B2 (pt)
BR (1) BR9609998A (pt)
CA (1) CA2229786C (pt)
CO (1) CO4480739A1 (pt)
CZ (1) CZ56698A3 (pt)
DZ (1) DZ2087A1 (pt)
GT (1) GT199600072A (pt)
HR (1) HRP960395B1 (pt)
HU (1) HUP9900170A3 (pt)
IL (1) IL122651A (pt)
MA (1) MA23966A1 (pt)
MY (1) MY113874A (pt)
NO (1) NO309814B1 (pt)
NZ (1) NZ312199A (pt)
OA (1) OA10669A (pt)
PE (1) PE12598A1 (pt)
PL (1) PL325170A1 (pt)
RU (1) RU2144921C1 (pt)
SK (1) SK23898A3 (pt)
TN (1) TNSN96109A1 (pt)
TR (1) TR199800339T1 (pt)
WO (1) WO1997007800A1 (pt)
YU (1) YU48396A (pt)
ZA (1) ZA967282B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000106A (es) 1997-08-01 1999-01-08 Pfizer Prod Inc Composiciones parenterales de alatroflaxacino
US7019142B2 (en) 1998-01-16 2006-03-28 Pfizer Inc. Process for preparing naphthyridones and intermediates
PA8466701A1 (es) * 1998-01-21 2000-09-29 Pfizer Prod Inc Comprimido de mesilato de trovafloxacino
US6114531A (en) * 1998-07-28 2000-09-05 Pfizer Inc. Process for preparing quinolone and naphthyridone carboxylic acids
HN1999000141A (es) * 1998-09-03 2000-06-19 Pfizer Prod Inc Procedimiento para preparar sales de trovafloxacina de adicion de acidos.
US6239141B1 (en) * 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids

Also Published As

Publication number Publication date
IL122651A0 (en) 1998-08-16
DZ2087A1 (fr) 2002-07-22
AP636A (en) 1998-04-09
JP3188476B2 (ja) 2001-07-16
SK23898A3 (en) 1999-05-07
KR100343909B1 (ko) 2003-04-10
CA2229786C (en) 2002-02-19
HUP9900170A2 (hu) 1999-05-28
HRP960395A2 (en) 1998-06-30
IL122651A (en) 2000-02-17
RU2144921C1 (ru) 2000-01-27
NZ312199A (en) 1999-06-29
AU704115B2 (en) 1999-04-15
TR199800339T1 (xx) 1998-06-22
AR003985A1 (es) 1998-09-30
MX9801664A (es) 1998-08-30
HRP960395B1 (en) 2001-12-31
CO4480739A1 (es) 1997-07-09
CZ56698A3 (cs) 1999-02-17
AU6367696A (en) 1997-03-19
TNSN96109A1 (fr) 2005-03-15
GT199600072A (es) 1998-02-14
MA23966A1 (fr) 1997-04-01
BR9609998A (pt) 1999-07-06
OA10669A (en) 2000-11-06
EP0850060A1 (en) 1998-07-01
KR19990044232A (ko) 1999-06-25
AP9600853A0 (en) 1996-10-31
ZA967282B (en) 1998-03-02
NO980862D0 (no) 1998-02-27
YU48396A (sh) 1998-12-23
WO1997007800A1 (en) 1997-03-06
MY113874A (en) 2002-06-29
NO980862L (no) 1998-02-27
NO309814B1 (no) 2001-04-02
JPH10511692A (ja) 1998-11-10
CA2229786A1 (en) 1997-03-06
CN1190889A (zh) 1998-08-19
PL325170A1 (en) 1998-07-06
HUP9900170A3 (en) 1999-11-29

Similar Documents

Publication Publication Date Title
CO5271691A1 (es) Nuevos compuestos
DE60025369D1 (de) Unterchlorige säure enthaltendes superoxidiertes wasser zur behandlung von wunden
PT772600E (pt) Compostos de imidazolilo substituido nas posicoes 1 e 2 para o tratamento da inflamacao
BRPI0213348A2 (pt) sistema para desinfectar água usando radiação ultravioleta(uv)
HUP0204182A3 (en) Use of fumaric acid derivatives for treating mitochondrial diseases
IT1207269B (it) Difenilbutilpiperazincarbossammidi, loro sali di addizione con acidi e composizioni farmaceutiche; procedimenti di fabbricazione ed uso.
AR034556A1 (es) Un derivado de fenilalanina, una composicion farmaceutica que comprende al derivado de fenilalanina, el uso del derivado y proceso para preparar dicho derivado
TR199900307T2 (xx) Y�ksek verimli ters osmoz i�lemi i�in y�ntem ve cihaz
MA27566A1 (fr) Inhibiteurs de 4-oxo-1-(3-phenyle substitue -1, 4-dihydro-1, 8-naphthyridine-3-carboxamide phosphodiesterase-4
DK0882049T3 (da) Eventuelt substituerede 8-cyan-1-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-quinolincarboxylsyrer og deres derivater
ZA837976B (en) Imidazolylalkylthienyl-tetrahydropyridazines and processes for their preparation
EA199900526A1 (ru) Применение производных 7-(2-окса-5,8-диазабицикло[4,3,0] нон-8-ил)-хинолонкарбоновой кислоты и -нафтиридонкарбоновой кислоты для лечения helicobacter pylori- инфекций и связанных с ними гастродуоденальных заболеваний
ATE399782T1 (de) Zur behandlung von schmerzen geeignete phenylcarbonsäureamidverbindungen
PL376439A1 (en) Multivalent metal salts of boronic acids for treating thrombosis
PE12598A1 (es) Formas zwitterionicas de trovafloxacina
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
BR0114697A (pt) Derivados em ponte de piperazina
ATE417856T1 (de) Motilidverbindungen
BR0209072A (pt) Aplicação de compostos de terra-rara para a prevenção de cálculo renal
NO20052562L (no) Anvendelse av distrontiumsalter av 2-[N,N-di(karboksylmetyl)amino]-3-cyano-4-karboksylmetyl-tiofen-5-karboksylsyre for fremstilling av medikamenter for behandlingen av gastro-duodenal smerte.
DE60103034D1 (de) Neue phenylheteroalkylamin-derivate
NO20033273D0 (no) Anvendelse av (R)-ibuprofen-metansulfonamid og salter derav til behandlingog forhindring av avstötning av transplanterte organer
NO923393L (no) Fremgangsmaate for inhibering av korrosjon i broenner som syrebehandle
ID16479A (id) Senyawa-senyawa pengobatan
HUP9801925A1 (hu) Nátrium/hidrogén-csere inhibítorok alkalmazása protozoák által okozott betegségek kezelésére alkalmas gyógyszerkészítmények előállítására

Legal Events

Date Code Title Description
FC Refusal